Logo image of ARBS.MI

ARTERRA BIOSCIENCE SPA (ARBS.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:ARBS - IT0005386369 - Common Stock

3.08 EUR
-0.04 (-1.28%)
Last: 1/13/2026, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, ARBS scores 4 out of 10 in our fundamental rating. ARBS was compared to 0 industry peers in the Unkown industry. While ARBS seems to be doing ok healthwise, there are quite some concerns on its profitability. ARBS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • ARBS had positive earnings in the past year.
  • In the past year ARBS had a positive cash flow from operations.
  • In the past 5 years ARBS has always been profitable.
  • In the past 5 years ARBS always reported a positive cash flow from operatings.
ARBS.MI Yearly Net Income VS EBIT VS OCF VS FCFARBS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

1.2 Ratios

  • The last Return On Invested Capital (13.11%) for ARBS is above the 3 year average (9.13%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.59%
ROE 16.33%
ROIC 13.11%
ROA(3y)9.93%
ROA(5y)10.02%
ROE(3y)11.74%
ROE(5y)12.1%
ROIC(3y)9.13%
ROIC(5y)9.66%
ARBS.MI Yearly ROA, ROE, ROICARBS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • ARBS's Profit Margin has been stable in the last couple of years.
  • ARBS's Operating Margin has been stable in the last couple of years.
  • ARBS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 46.43%
PM (TTM) 42.38%
GM 63.6%
OM growth 3Y0.28%
OM growth 5Y-1.05%
PM growth 3Y3.33%
PM growth 5Y0.25%
GM growth 3Y-2.51%
GM growth 5Y-0.98%
ARBS.MI Yearly Profit, Operating, Gross MarginsARBS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

6

2. Health

2.1 Basic Checks

  • ARBS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for ARBS remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, ARBS has less shares outstanding
  • The debt/assets ratio for ARBS has been reduced compared to a year ago.
ARBS.MI Yearly Shares OutstandingARBS.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ARBS.MI Yearly Total Debt VS Total AssetsARBS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • An Altman-Z score of 7.45 indicates that ARBS is not in any danger for bankruptcy at the moment.
  • The Debt to FCF ratio of ARBS is 0.30, which is an excellent value as it means it would take ARBS, only 0.30 years of fcf income to pay off all of its debts.
  • ARBS has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
  • Even though the debt/equity ratio score it not favorable for ARBS, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.3
Altman-Z 7.45
ROIC/WACC1.42
WACC9.26%
ARBS.MI Yearly LT Debt VS Equity VS FCFARBS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.3 Liquidity

  • ARBS has a Current Ratio of 7.40. This indicates that ARBS is financially healthy and has no problem in meeting its short term obligations.
  • A Quick Ratio of 6.31 indicates that ARBS has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 7.4
Quick Ratio 6.31
ARBS.MI Yearly Current Assets VS Current LiabilitesARBS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

4

3. Growth

3.1 Past

  • ARBS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.48%, which is quite impressive.
  • The Earnings Per Share has been growing by 10.01% on average over the past years. This is quite good.
  • The Revenue has grown by 13.44% in the past year. This is quite good.
  • The Revenue has been growing by 9.02% on average over the past years. This is quite good.
EPS 1Y (TTM)37.48%
EPS 3Y8.02%
EPS 5Y10.01%
EPS Q2Q%109.79%
Revenue 1Y (TTM)13.44%
Revenue growth 3Y2.94%
Revenue growth 5Y9.02%
Sales Q2Q%14.28%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ARBS.MI Yearly Revenue VS EstimatesARBS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.27 indicates a reasonable valuation of ARBS.
  • Compared to an average S&P500 Price/Earnings ratio of 27.38, ARBS is valued rather cheaply.
Industry RankSector Rank
PE 10.27
Fwd PE N/A
ARBS.MI Price Earnings VS Forward Price EarningsARBS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 19.78
EV/EBITDA 7.22
ARBS.MI Per share dataARBS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.03
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

  • ARBS has a Yearly Dividend Yield of 4.19%, which is a nice return.
  • Compared to an average S&P500 Dividend Yield of 1.85, ARBS pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.19%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • ARBS pays out 44.46% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP44.46%
EPS Next 2YN/A
EPS Next 3YN/A
ARBS.MI Yearly Income VS Free CF VS DividendARBS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M
ARBS.MI Dividend Payout.ARBS.MI Dividend Payout, showing the Payout Ratio.ARBS.MI Dividend Payout.PayoutRetained Earnings

More info and screens

ARTERRA BIOSCIENCE SPA

BIT:ARBS (1/13/2026, 7:00:00 PM)

3.08

-0.04 (-1.28%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.16%
Inst Owner ChangeN/A
Ins Owners46.87%
Ins Owner ChangeN/A
Market Cap20.51M
Revenue(TTM)4.49M
Net Income(TTM)1.90M
Analysts82.86
Price Target3.88 (25.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.19%
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP44.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.56%
PT rev (3m)5.56%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.27
Fwd PE N/A
P/S 4.56
P/FCF 19.78
P/OCF 10.79
P/B 1.76
P/tB 1.76
EV/EBITDA 7.22
EPS(TTM)0.3
EY9.74%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.16
FCFY5.06%
OCF(TTM)0.29
OCFY9.27%
SpS0.67
BVpS1.75
TBVpS1.75
PEG (NY)N/A
PEG (5Y)1.03
Graham Number3.44
Profitability
Industry RankSector Rank
ROA 13.59%
ROE 16.33%
ROCE 16.27%
ROIC 13.11%
ROICexc 17.92%
ROICexgc 17.98%
OM 46.43%
PM (TTM) 42.38%
GM 63.6%
FCFM 23.07%
ROA(3y)9.93%
ROA(5y)10.02%
ROE(3y)11.74%
ROE(5y)12.1%
ROIC(3y)9.13%
ROIC(5y)9.66%
ROICexc(3y)15.47%
ROICexc(5y)17.58%
ROICexgc(3y)15.82%
ROICexgc(5y)18.81%
ROCE(3y)11.33%
ROCE(5y)12.02%
ROICexgc growth 3Y-16.84%
ROICexgc growth 5Y-17%
ROICexc growth 3Y-14.48%
ROICexc growth 5Y-12.8%
OM growth 3Y0.28%
OM growth 5Y-1.05%
PM growth 3Y3.33%
PM growth 5Y0.25%
GM growth 3Y-2.51%
GM growth 5Y-0.98%
F-Score6
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.3
Debt/EBITDA 0.11
Cap/Depr 269.44%
Cap/Sales 19.23%
Interest Coverage 250
Cash Conversion 78.96%
Profit Quality 54.44%
Current Ratio 7.4
Quick Ratio 6.31
Altman-Z 7.45
F-Score6
WACC9.26%
ROIC/WACC1.42
Cap/Depr(3y)76.68%
Cap/Depr(5y)90.12%
Cap/Sales(3y)7.07%
Cap/Sales(5y)10.14%
Profit Quality(3y)69.73%
Profit Quality(5y)57.78%
High Growth Momentum
Growth
EPS 1Y (TTM)37.48%
EPS 3Y8.02%
EPS 5Y10.01%
EPS Q2Q%109.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.44%
Revenue growth 3Y2.94%
Revenue growth 5Y9.02%
Sales Q2Q%14.28%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y62.77%
EBIT growth 3Y3.23%
EBIT growth 5Y7.88%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-57.65%
FCF growth 3Y-20.26%
FCF growth 5Y25.42%
OCF growth 1Y3.72%
OCF growth 3Y-8.67%
OCF growth 5Y-9.31%

ARTERRA BIOSCIENCE SPA / ARBS.MI FAQ

Can you provide the ChartMill fundamental rating for ARTERRA BIOSCIENCE SPA?

ChartMill assigns a fundamental rating of 4 / 10 to ARBS.MI.


What is the valuation status of ARTERRA BIOSCIENCE SPA (ARBS.MI) stock?

ChartMill assigns a valuation rating of 1 / 10 to ARTERRA BIOSCIENCE SPA (ARBS.MI). This can be considered as Overvalued.


Can you provide the profitability details for ARTERRA BIOSCIENCE SPA?

ARTERRA BIOSCIENCE SPA (ARBS.MI) has a profitability rating of 3 / 10.


How sustainable is the dividend of ARTERRA BIOSCIENCE SPA (ARBS.MI) stock?

The dividend rating of ARTERRA BIOSCIENCE SPA (ARBS.MI) is 4 / 10 and the dividend payout ratio is 44.46%.